Sempra reports Q1 2026 results on Tuesday with a notably one-sided analyst consensus and a stock that has retreated sharply from its highs — a setup where the Street's conviction will be tested against the actual numbers.
Options positioning into the print is almost conspicuously calm. The put/call ratio is running at 0.30, essentially flat with its 20-day average of 0.30 and barely a rounding error below. There is no discernible rush for downside protection — unusual for a stock down 7% over the past month. That absence of options defensiveness suggests this is valuation-led softness rather than event-driven fear. The stock closed at $91.53, sitting about 12% below the Street's mean price target of $104, and trading at a P/E of around 17.4x — a multiple that has compressed by roughly 1.5 turns in thirty days.
The analyst community is leaning hard in one direction. Sentiment ranks in the 98th percentile for analyst recommendation differential — meaning the distribution of ratings leans bullish relative to almost the entire universe. Morgan Stanley trimmed its target modestly to $104 in late April while keeping an Overweight. Truist initiated fresh coverage at Buy with a $108 target on the same day. Barclays had already raised its target to $105 from $95 in mid-April. Wells Fargo holds a $115 target. The bear case centres on declining Infrastructure segment earnings, wildfire liability exposure in California, cost overruns in the LNG development programme, and the drag from rising net interest expenses in the Parent & Other segment. Bulls point to the 80% Oncor ownership in Texas, a deep LNG project pipeline, and the regulatory clarification improving the long-run terminal value of the California utilities franchise.
Short selling pressure is genuinely modest and easing. Short Interest as a percentage of free float has declined from around 1.65% in mid-April to 1.36% now — a steady retreat that shows no sign of fresh bearish conviction building ahead of the print. Borrow conditions reinforce that read: the cost to borrow has dropped sharply over the past week to just 0.33%, and availability in the lending pool is loose. The ORTEX short score of 30.6 is unremarkable. Whatever pressure Sempra has faced this past month has not come from short sellers piling in.
The institutional base is anchored and stable. Vanguard holds 11.7% and added shares in Q1. JP Morgan Asset Management added more than 3.8 million shares in the quarter. Insider activity over the past 90 days reflects a net purchase position — three independent directors bought shares in early March near current prices, suggesting the board views $91–$93 as reasonable value. Those purchases come alongside routine CFO sales that appear compensation-related.
Tuesday's print is ultimately a test of whether Sempra's infrastructure growth story can overcome the mounting interest expense burden and deliver earnings that justify the Street's stubborn optimism at a multiple that has already re-rated lower.
See the live data behind this article on ORTEX.
Open SRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
